1. Home
  2. ACDC vs COLL Comparison

ACDC vs COLL Comparison

Compare ACDC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProFrac Holding Corp.

ACDC

ProFrac Holding Corp.

HOLD

Current Price

$6.39

Market Cap

971.3M

Sector

Energy

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$35.52

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACDC
COLL
Founded
2014
2002
Country
United States
United States
Employees
N/A
423
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.3M
1.2B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
ACDC
COLL
Price
$6.39
$35.52
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$5.83
$51.17
AVG Volume (30 Days)
1.4M
461.1K
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
$1,941,800,000.00
$780,567,000.00
Revenue This Year
N/A
$5.93
Revenue Next Year
$6.37
N/A
P/E Ratio
N/A
$21.08
Revenue Growth
N/A
23.62
52 Week Low
$3.08
$23.23
52 Week High
$10.70
$50.79

Technical Indicators

Market Signals
Indicator
ACDC
COLL
Relative Strength Index (RSI) 59.77 31.36
Support Level $3.48 $34.29
Resistance Level $7.47 $36.20
Average True Range (ATR) 0.49 1.31
MACD 0.08 -0.04
Stochastic Oscillator 56.05 17.58

Price Performance

Historical Comparison
ACDC
COLL

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: